diabetes-mellitus

Documents about diabetes-mellitus

• Empa PASS on Urinary Tract Malignancies#146344ClinicalTrials.gov
• Korean Post-marketing Surveillance for Kombiglyze XR®#152384ClinicalTrials.gov
• Insulin Glargine, INITIATE Metabolic and Economic Outcomes of Lantus#154848ClinicalTrials.gov
• US Inhaled Insulin Therapeutic Choice Questionnaire Study#201703ClinicalTrials.gov
• Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance#6909OpenAlex
• PREVALENCE OF TRADITIONAL MEDICINE USE AND ITS ASSOCIATED FACTORS IN DIABETES MELLITUS MANAGEMENT IN ANAMBRA STATE, NIGERIA#20824DataCite
• PREVALENCE OF TRADITIONAL MEDICINE USE AND ITS ASSOCIATED FACTORS IN DIABETES MELLITUS MANAGEMENT IN ANAMBRA STATE, NIGERIA#20825DataCite
• Insulin Glargine Injection Treatment in Place of Thiazolidinedione (TZD), Sulfonylurea, or Metformin in Triple Agent Therapy for Type 2 Diabetes Mellitus (T2DM) Adult Subjects With Unsatisfactory Control#28577ClinicalTrials.gov
• Dose-ranging Study to Evaluate the Effectiveness and Tolerability of MK0736 in Patients With Type 2 Diabetes Mellitus (T2DM) and Hypertension (0736-007)#127726ClinicalTrials.gov
• To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin#158164ClinicalTrials.gov
• Frequency of Episodes of Hypoglycaemia During Treatment With Biphasic Insulin Aspart 30 in Type 2 Diabetes#141167ClinicalTrials.gov
• Effect of Metformin in Patients With Type-1 Diabetes With Inadequate Glycaemic Control by Insulin and Diet#152366ClinicalTrials.gov
• Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes#162430ClinicalTrials.gov
• International Diabetes Federation 2017#6098OpenAlex
• Towards Optimal Screening and Management of Coronary Artery Disease in Diabetes: TOSCANA Study#18817ClinicalTrials.gov
• Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 Diabetes#28472ClinicalTrials.gov
• A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes#28571ClinicalTrials.gov
• Virtual Health Coaching With Artificial Intelligence for Glycemic Control in Type 2 Diabetes#67761ClinicalTrials.gov
• BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 Diabetes#67852ClinicalTrials.gov
• Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)#121294ClinicalTrials.gov
• Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes#126043ClinicalTrials.gov
• Vildagliptin Compared to Gliclazide in Combination With Metformin in Patients With Type 2 Diabetes#126091ClinicalTrials.gov
• Study Evaluating Safety, Tolerability, And Action Of OAP-189 In Subjects With Type 2 Diabetes On Metformin#127805ClinicalTrials.gov
• Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixi#127811ClinicalTrials.gov
• The Effect of Diabetes Education Digital Games and Video Animation on Quality of Life#136222ClinicalTrials.gov
• Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes#136262ClinicalTrials.gov
• Effects of Pioglitazone on High-density Lipoprotein (HDL) Function in Persons With Diabetes#136277ClinicalTrials.gov
• Breast Milk Hormones and Early Infant Growth of Women With Gestational Diabetes Mellitus#141172ClinicalTrials.gov
• Safety Study of Weekly Semaglutide in Chilean Participants With Type 2 Diabetes#141182ClinicalTrials.gov
• Canakinumab in Patients With COVID-19 and Type 2 Diabetes#141183ClinicalTrials.gov
• Effect of Case-Management Using Home Monitoring on Diabetes and Blood Pressure Outcomes#143695ClinicalTrials.gov
• Amlexanox for Type 2 Diabetes and Obesity#143764ClinicalTrials.gov
• Safety, Tolerability and Pharmacodynamics of CYT013-IL1bQb in Patients With Type 2 Diabetes#148555ClinicalTrials.gov
• Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)#152569ClinicalTrials.gov
• Effects of LY2189265 on Glycemic Control in Participants With Type 2 Diabetes#152592ClinicalTrials.gov
• 24/7 Closed-loop in Older Subjects With Type 1 Diabetes#152594ClinicalTrials.gov
• Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes#154852ClinicalTrials.gov
• Assessment of Dapagliflozin on Vascular Health in Patients With Type 2 Diabetes#158148ClinicalTrials.gov
• Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira#158192ClinicalTrials.gov
• Cardiovascular Health and Text Messaging-Diabetes Mellitus (CHAT-DM) Study#175003ClinicalTrials.gov
• Bedtime Insulins and Oral Antihyperglycemic Drugs in Type 2 Diabetes#181713ClinicalTrials.gov
• Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes#195489ClinicalTrials.gov
• Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)#195525ClinicalTrials.gov
• Impact Evaluation of a Mobile Health App to Improve Self-control and Health Outcomes of Patients With Type 2 Diabetes Mellitus (T2DM): Pilot Study "NOVAME"#18776ClinicalTrials.gov
• Efficacy of 500µg Roflumilast Once Daily Versus Placebo Over 12 Weeks in Patients With Diabetes Mellitus Type 2. A Double Blind, Parallel Group, Proof of Concept Clinical Study#143752ClinicalTrials.gov
• Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus#146416ClinicalTrials.gov
• Efficacy and Safety of LixiLan Versus Insulin Glargine Alone Both With Metformin in Japanese With Type 2 Diabetes Mellitus Inadequately Controlled on Basal Insulin and Oral Antidiabetic Drugs#172510ClinicalTrials.gov
• A Lifestyle Intervention for Type 2 Diabetes Patients in Kuwait and Its Impact on Glycaemic Control#141206ClinicalTrials.gov
• Feasibility Study of Extended Wear Insulin Infusion Set Options During Home Use in People With Type 1 Diabetes#143735ClinicalTrials.gov
• Comparison of NN5401 Versus Insulin Glargine, Both Combined With Metformin Treatment, in Subjects With Type 2 Diabetes#195513ClinicalTrials.gov